known about the cellular and molecular defects associated with these disorders. The generation of induced pluripotent stem (iPS) cells from autistic patients, combined with in vitro neuronal differentiation, opens the door to establishing and characterizing cellular model systems for ASDs and other human neurobehavioral disorders. We have generated iPS cells from somatic cells from patients with syndromic forms of autism and have differentiated these iPS cells into neurons in vitro. We have identified cellular phenotypes in neurons from some of these patients that provide novel insights into the underlying basis of autism. For instance we have found defects in the generation of excitatory and inhibitory neurons, catecholaminergic cells and in the capacity of some of these cells to generate dendritic arbors. I will discuss some of the challenges of this approach and some of the experiments that are underway to further validate the system. This strategy is allowing us to characterize patient derived cells in terms of neuronal differentiation, dendritic arborization, synapse formation, Ca 2+ signaling, and gene expression using a variety of in vitro cell biological assays and will provide new insights into the underlying biological basis of autism. Rare genome copy number variations (CNVs) caused by microdel/dup of chromosome play significant roles in psychiatric disorders such as autism and schizophrenia. Altered functions of genes inside/near CNVs contribute to phenotypes of the disorders. Developmental neuropsychiatric syndromes associated with 7q11.23 CNV have been identified, del being with Williams-Buren syndrome (WBS). WBS shows unique neurocognitive features, including low IQ, deficits in visuospatial abilities, hypersensitivity to sounds, increased anxiety, and hypersociability, the last of which is mirror contract to behavioral characteristics of autism. Interestingly, 7q11.23 dup is associated with autism, suggesting that genes affected by the CNV may be crucial for development of social neurocircuitry. One of genes in the region, GTF2I, has been implicated in the hypersociability and visuospatial deficits of WBS by genotype-phenotype correlation studies of patients with atypical deletions. To clarify the involvement of GTF2I in neurocognitive function, especially social behaviors, we have characterized Gtf2i-deficient mice. We found that homozygous deletion of Gtf2i causes lethality during embryonic development with neural tube closure defects and excencephaly. Gtf2i heterozygous animals show no gross changes in brain structure or development. Furthermore, heterozygotes show no alterations in spatial memory, but show alterations in the recognition of novel objects. Interestingly, they show increased social interaction with unfamiliar mice and do not show typical social habituation processes, reminiscent of the hypersociability observed in WBS patients. The mice do not appear to show increased anxiety, supporting a specific effect of Gtf2i on defined domains of the WBS phenotype. These data indicate that Gtf2i is involved in embryonic development and the development of social neurocircuitry and that GTF2I haploinsufficiency could be a contributor to the hypersociability in WBS. Autism is a major mental illness defined by three diagnostic behavioral criteria: (1) unusual reciprocal social interactions, (2) impaired communication, (3) repetitive behaviors with restricted interests. As candidate genes linked to autism are identified, mice with targeted mutations in these genes are becoming available. Our laboratory designs mouse behavioral paradigms with conceptual analogies to these three diagnostic symptoms. Reciprocal social interactions are assayed longitudinally across developmental stages with simple automated measures of sociability, and with in-depth scoring of reciprocal social interactions. Communication in mice is assessed by the emission, detection, and responses to olfactory and auditory social cues. Repetitive behaviors are assayed for spontaneous stereotyped motor behaviors, repetitive self-grooming, perseveration during the reversal phase of T-maze and Morris water maze spatial tasks, and restricted exploration of complex environments. Comprehensive control parameters are scored to avoid over-interpretation of artifacts. Behavioral assays relevant to the associated symptoms of autism, including delays in early developmental milestones, intellectual impairments, anxiety, seizures, hypo-and hyperreactivity to sensory stimuli, and sleep disruption, may provide further insights into the phenotypes of a mouse model of autism spectrum disorders. BTBR T + tf/J, an inbred strain that displays autism-relevant traits on many of these tasks, will be used to illustrate phenotypes of a robust mouse model of autism. Targeted mutations in candidate genes for autism will be described, including Shank3 mutant mice. Early preclinical results will be presented on drug treatments that reverse components of autism-relevant behavioral phenotypes in mouse models. Autism is a highly variable brain development disorder and has a strong genetic basis. Pax6 transcription factor is a pivotal player in brain development and maintenance. It is expressed in embryonic and adult neural stem cells, in astrocytes in the entire central nervous system, and in neurons in the olfactory bulb, amygdala, thalamus, and cerebellum, functioning in highly context-dependent manners. We have recently reported that Pax6 heterozygous mutant (Pax6 +/−) rats with a spontaneous mutation in the Pax6 gene show impaired prepulse inhibition (PPI), a response showing a sensorymotor gating function. We further examined behaviors of Pax6 +/− male rats and revealed that they exhibited abnormality in social interaction (more aggression and withdrawal) and in addition to impairment in rearing activity and in fear-conditioned memory. Ultrasound vocalization in Pax6 +/− rat pups was normal in male but abnormal in female. Moreover, treatment with clozapine, an anti-psychotic drug that shows strong binding to HTR2A, successfully recovered the defects in PPI, but not in fear-conditioned memory. Interestingly, we found decreased 5-HT levels both in serum and in the hippocampus of Pax6 +/− rats, representing the first rodent model that shows impaired 5-HT conditions. Together with our genetical data and results in other literatures, we would like to propose Pax6 +/− rats as another model for autism spectrum disorders. Motivation is a brain process that makes a subject move toward a goal. We have shown that the level of motivation in instrumental task performance is well described by external factors (e.g., size or timing of reward) and internal factors (e.g., thirst or hunger) in macaque monkeys (Minamimoto et al., 2009 ). In addition, motivation is also affected by mood. For example, depression is associated with low motivation in general. We have been studying the neural mechanism of controlling motivation by using positron emission tomography (PET). To identify the motivational circuit controlled by internal factors, we performed an activation study by PET, in which the monkey continuously performed instrumental task for water rewards from thirst to satiation. It was revealed that the orbitofrontal cortex and ventral striatum were activated when the monkey was thirsty, suggesting that these two brain regions are critical for adjusting motivation based on internal signals. To identify the motivational mechanism related to mood, we studied low motivational state with a monkey model of hypothyroidism, which is associated with symptoms such as fatigue or depression. Administration of antithyroid agent (metimazole) to monkeys (n = 5) for a few months induced mild hypothyroidism (thyroxin level became less than half of normal). In this hypothyroid state, the monkeys' task performance worsened without
